Monoclonal antibody | Panitumumab [32] | 6 mg/kg every two weeks. No loading dose is required. This cycle may be repeated. | 1 hr |
|
Monoclonal antibody | Fresolimumab (anti-TGF-β) [43] | 3 mg/kg every two weeks. This cycle may be repeated. | 1.5 hr |
|
Monoclonal antibody | Anti-IL-10 Est. from [44] | 3 mg/kg every two weeks. This cycle may be repeated. | 1.5 hr |
|
RTK inhibitor | Sunitinib (anti-Treg) [45] | A Sunitinib capsule is given daily for 28 straight days followed by two weeks of rest. In total, 23.447 mg of sunitinib are administered per each 6-week cycle. This cycle may be repeated. | None |
|
Adoptive cell transfer | NK cells [46] | An intravenous injection of 2 × 107 NK cells per kg is given weekly. This cycle may be repeated. | 1 hr |
|
Adoptive cell transfer | CTL [47] | Five intravenous injections of 1 × 1010 CTL per m2 are given every 5 days and they are followed by 45 days of rest. This 65-day cycle may be repeated. | 1 hr |
|